nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—NPR1—artery—uterine cancer	0.0234	0.0518	CbGeAlD
Nitroglycerin—GUCY1A2—myometrium—uterine cancer	0.0193	0.0428	CbGeAlD
Nitroglycerin—ALDH2—exocrine gland—uterine cancer	0.0185	0.0409	CbGeAlD
Nitroglycerin—GUCY1A2—uterine cervix—uterine cancer	0.015	0.0333	CbGeAlD
Nitroglycerin—GUCY1A3—myometrium—uterine cancer	0.0122	0.0269	CbGeAlD
Nitroglycerin—GUCY1B3—myometrium—uterine cancer	0.0121	0.0267	CbGeAlD
Nitroglycerin—NPR1—myometrium—uterine cancer	0.0113	0.025	CbGeAlD
Nitroglycerin—GUCY1A2—female reproductive system—uterine cancer	0.0113	0.0249	CbGeAlD
Nitroglycerin—ALDH2—myometrium—uterine cancer	0.0103	0.0227	CbGeAlD
Nitroglycerin—GUCY1A3—uterine cervix—uterine cancer	0.00947	0.021	CbGeAlD
Nitroglycerin—GUCY1B3—uterine cervix—uterine cancer	0.0094	0.0208	CbGeAlD
Nitroglycerin—GUCY1A3—decidua—uterine cancer	0.00903	0.02	CbGeAlD
Nitroglycerin—GUCY1B3—decidua—uterine cancer	0.00896	0.0198	CbGeAlD
Nitroglycerin—NPR1—epithelium—uterine cancer	0.00887	0.0196	CbGeAlD
Nitroglycerin—GUCY1A3—renal system—uterine cancer	0.00886	0.0196	CbGeAlD
Nitroglycerin—GUCY1B3—renal system—uterine cancer	0.0088	0.0195	CbGeAlD
Nitroglycerin—NPR1—uterine cervix—uterine cancer	0.0088	0.0195	CbGeAlD
Nitroglycerin—GUCY1A3—endometrium—uterine cancer	0.00857	0.019	CbGeAlD
Nitroglycerin—NPR1—smooth muscle tissue—uterine cancer	0.00855	0.0189	CbGeAlD
Nitroglycerin—GUCY1B3—endometrium—uterine cancer	0.00851	0.0188	CbGeAlD
Nitroglycerin—NPR1—decidua—uterine cancer	0.00838	0.0185	CbGeAlD
Nitroglycerin—GUCY1A3—mammalian vulva—uterine cancer	0.00829	0.0183	CbGeAlD
Nitroglycerin—NPR1—renal system—uterine cancer	0.00823	0.0182	CbGeAlD
Nitroglycerin—GUCY1B3—mammalian vulva—uterine cancer	0.00823	0.0182	CbGeAlD
Nitroglycerin—ALDH2—uterine cervix—uterine cancer	0.00798	0.0177	CbGeAlD
Nitroglycerin—NPR1—endometrium—uterine cancer	0.00796	0.0176	CbGeAlD
Nitroglycerin—GUCY1A3—uterus—uterine cancer	0.0079	0.0175	CbGeAlD
Nitroglycerin—GUCY1B3—uterus—uterine cancer	0.00784	0.0173	CbGeAlD
Nitroglycerin—ALDH2—smooth muscle tissue—uterine cancer	0.00776	0.0172	CbGeAlD
Nitroglycerin—NPR1—mammalian vulva—uterine cancer	0.0077	0.017	CbGeAlD
Nitroglycerin—ALDH2—decidua—uterine cancer	0.00761	0.0168	CbGeAlD
Nitroglycerin—ALDH2—renal system—uterine cancer	0.00747	0.0165	CbGeAlD
Nitroglycerin—NPR1—uterus—uterine cancer	0.00733	0.0162	CbGeAlD
Nitroglycerin—ALDH2—endometrium—uterine cancer	0.00722	0.016	CbGeAlD
Nitroglycerin—GUCY1A3—female reproductive system—uterine cancer	0.0071	0.0157	CbGeAlD
Nitroglycerin—GUCY1B3—female reproductive system—uterine cancer	0.00705	0.0156	CbGeAlD
Nitroglycerin—ALDH2—mammalian vulva—uterine cancer	0.00699	0.0155	CbGeAlD
Nitroglycerin—ALDH2—uterus—uterine cancer	0.00665	0.0147	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—uterine cancer	0.00659	0.0146	CbGeAlD
Nitroglycerin—NPR1—female reproductive system—uterine cancer	0.00659	0.0146	CbGeAlD
Nitroglycerin—GUCY1A3—female gonad—uterine cancer	0.00646	0.0143	CbGeAlD
Nitroglycerin—GUCY1A3—vagina—uterine cancer	0.00642	0.0142	CbGeAlD
Nitroglycerin—GUCY1B3—female gonad—uterine cancer	0.00641	0.0142	CbGeAlD
Nitroglycerin—GUCY1B3—vagina—uterine cancer	0.00637	0.0141	CbGeAlD
Nitroglycerin—NPR1—female gonad—uterine cancer	0.006	0.0133	CbGeAlD
Nitroglycerin—ALDH2—female reproductive system—uterine cancer	0.00598	0.0132	CbGeAlD
Nitroglycerin—NPR1—vagina—uterine cancer	0.00596	0.0132	CbGeAlD
Nitroglycerin—ALDH2—female gonad—uterine cancer	0.00544	0.012	CbGeAlD
Nitroglycerin—ALDH2—vagina—uterine cancer	0.00541	0.012	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—uterine cancer	0.00415	0.00918	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—uterine cancer	0.00412	0.00912	CbGeAlD
Nitroglycerin—NPR1—lymph node—uterine cancer	0.00386	0.00853	CbGeAlD
Nitroglycerin—ALDH2—lymph node—uterine cancer	0.0035	0.00774	CbGeAlD
Nitroglycerin—Palpitations—Progesterone—uterine cancer	0.00204	0.00372	CcSEcCtD
Nitroglycerin—Hyperventilation—Doxorubicin—uterine cancer	0.00203	0.00371	CcSEcCtD
Nitroglycerin—Stomatitis—Dactinomycin—uterine cancer	0.00203	0.00371	CcSEcCtD
Nitroglycerin—Loss of consciousness—Progesterone—uterine cancer	0.00203	0.0037	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Etoposide—uterine cancer	0.00202	0.00369	CcSEcCtD
Nitroglycerin—Paralysis—Doxorubicin—uterine cancer	0.00202	0.00368	CcSEcCtD
Nitroglycerin—Burning sensation—Doxorubicin—uterine cancer	0.00202	0.00368	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00195	0.00356	CcSEcCtD
Nitroglycerin—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00351	CcSEcCtD
Nitroglycerin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00349	CcSEcCtD
Nitroglycerin—Confusional state—Progesterone—uterine cancer	0.0019	0.00346	CcSEcCtD
Nitroglycerin—Dermatitis atopic—Doxorubicin—uterine cancer	0.00189	0.00345	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Progesterone—uterine cancer	0.00188	0.00344	CcSEcCtD
Nitroglycerin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00343	CcSEcCtD
Nitroglycerin—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00342	CcSEcCtD
Nitroglycerin—Infection—Progesterone—uterine cancer	0.00187	0.00341	CcSEcCtD
Nitroglycerin—Pharyngitis—Dactinomycin—uterine cancer	0.00186	0.00339	CcSEcCtD
Nitroglycerin—Shock—Progesterone—uterine cancer	0.00185	0.00338	CcSEcCtD
Nitroglycerin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00185	0.00337	CcSEcCtD
Nitroglycerin—Nervous system disorder—Progesterone—uterine cancer	0.00185	0.00337	CcSEcCtD
Nitroglycerin—Tachycardia—Progesterone—uterine cancer	0.00184	0.00335	CcSEcCtD
Nitroglycerin—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00335	CcSEcCtD
Nitroglycerin—Skin disorder—Progesterone—uterine cancer	0.00183	0.00334	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Progesterone—uterine cancer	0.00182	0.00332	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00323	CcSEcCtD
Nitroglycerin—Hypotension—Progesterone—uterine cancer	0.00176	0.00321	CcSEcCtD
Nitroglycerin—Flushing—Dactinomycin—uterine cancer	0.00174	0.00317	CcSEcCtD
Nitroglycerin—Vasodilation procedure—Epirubicin—uterine cancer	0.00172	0.00314	CcSEcCtD
Nitroglycerin—Vasodilation—Epirubicin—uterine cancer	0.00172	0.00314	CcSEcCtD
Nitroglycerin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00314	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00311	CcSEcCtD
Nitroglycerin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00309	CcSEcCtD
Nitroglycerin—Paraesthesia—Progesterone—uterine cancer	0.00169	0.00309	CcSEcCtD
Nitroglycerin—Dyspnoea—Progesterone—uterine cancer	0.00168	0.00306	CcSEcCtD
Nitroglycerin—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00306	CcSEcCtD
Nitroglycerin—Somnolence—Progesterone—uterine cancer	0.00167	0.00305	CcSEcCtD
Nitroglycerin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00305	CcSEcCtD
Nitroglycerin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00304	CcSEcCtD
Nitroglycerin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00302	CcSEcCtD
Nitroglycerin—Sweating increased—Etoposide—uterine cancer	0.00165	0.00301	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00301	CcSEcCtD
Nitroglycerin—Erythema—Dactinomycin—uterine cancer	0.00163	0.00298	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00163	0.00297	CcSEcCtD
Nitroglycerin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00291	CcSEcCtD
Nitroglycerin—Vasodilation procedure—Doxorubicin—uterine cancer	0.00159	0.00291	CcSEcCtD
Nitroglycerin—Vasodilation—Doxorubicin—uterine cancer	0.00159	0.00291	CcSEcCtD
Nitroglycerin—Atrioventricular block—Epirubicin—uterine cancer	0.00156	0.00285	CcSEcCtD
Nitroglycerin—Feeling abnormal—Progesterone—uterine cancer	0.00155	0.00283	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Progesterone—uterine cancer	0.00154	0.00281	CcSEcCtD
Nitroglycerin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0028	CcSEcCtD
Nitroglycerin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00278	CcSEcCtD
Nitroglycerin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00277	CcSEcCtD
Nitroglycerin—Infestation NOS—Etoposide—uterine cancer	0.00151	0.00276	CcSEcCtD
Nitroglycerin—Infestation—Etoposide—uterine cancer	0.00151	0.00276	CcSEcCtD
Nitroglycerin—Urticaria—Progesterone—uterine cancer	0.0015	0.00273	CcSEcCtD
Nitroglycerin—Dermatitis contact—Epirubicin—uterine cancer	0.0015	0.00273	CcSEcCtD
Nitroglycerin—Abdominal pain—Progesterone—uterine cancer	0.00149	0.00272	CcSEcCtD
Nitroglycerin—Body temperature increased—Progesterone—uterine cancer	0.00149	0.00272	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.00269	CcSEcCtD
Nitroglycerin—Stomatitis—Etoposide—uterine cancer	0.00147	0.00269	CcSEcCtD
Nitroglycerin—Atrioventricular block—Doxorubicin—uterine cancer	0.00144	0.00263	CcSEcCtD
Nitroglycerin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00257	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00255	CcSEcCtD
Nitroglycerin—Hypersensitivity—Progesterone—uterine cancer	0.00139	0.00253	CcSEcCtD
Nitroglycerin—Dermatitis contact—Doxorubicin—uterine cancer	0.00138	0.00253	CcSEcCtD
Nitroglycerin—Coma—Epirubicin—uterine cancer	0.00138	0.00252	CcSEcCtD
Nitroglycerin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00247	CcSEcCtD
Nitroglycerin—Asthenia—Progesterone—uterine cancer	0.00135	0.00247	CcSEcCtD
Nitroglycerin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00246	CcSEcCtD
Nitroglycerin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00246	CcSEcCtD
Nitroglycerin—Pruritus—Progesterone—uterine cancer	0.00133	0.00243	CcSEcCtD
Nitroglycerin—Infection—Dactinomycin—uterine cancer	0.00132	0.00241	CcSEcCtD
Nitroglycerin—Coma—Doxorubicin—uterine cancer	0.00128	0.00233	CcSEcCtD
Nitroglycerin—Cardiac disorder—Etoposide—uterine cancer	0.00126	0.0023	CcSEcCtD
Nitroglycerin—Flushing—Etoposide—uterine cancer	0.00126	0.0023	CcSEcCtD
Nitroglycerin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00229	CcSEcCtD
Nitroglycerin—Dizziness—Progesterone—uterine cancer	0.00124	0.00227	CcSEcCtD
Nitroglycerin—Angiopathy—Etoposide—uterine cancer	0.00123	0.00224	CcSEcCtD
Nitroglycerin—Immune system disorder—Etoposide—uterine cancer	0.00122	0.00223	CcSEcCtD
Nitroglycerin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00223	CcSEcCtD
Nitroglycerin—Eczema—Epirubicin—uterine cancer	0.00122	0.00223	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Etoposide—uterine cancer	0.00122	0.00223	CcSEcCtD
Nitroglycerin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.0022	CcSEcCtD
Nitroglycerin—Vomiting—Progesterone—uterine cancer	0.0012	0.00218	CcSEcCtD
Nitroglycerin—Renal failure acute—Epirubicin—uterine cancer	0.00119	0.00217	CcSEcCtD
Nitroglycerin—Rash—Progesterone—uterine cancer	0.00119	0.00217	CcSEcCtD
Nitroglycerin—Dermatitis—Progesterone—uterine cancer	0.00119	0.00216	CcSEcCtD
Nitroglycerin—Headache—Progesterone—uterine cancer	0.00118	0.00215	CcSEcCtD
Nitroglycerin—Hot flush—Epirubicin—uterine cancer	0.00117	0.00214	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00116	0.00212	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Epirubicin—uterine cancer	0.00116	0.00212	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00113	0.00207	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—uterine cancer	0.00113	0.00206	CcSEcCtD
Nitroglycerin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00206	CcSEcCtD
Nitroglycerin—Nausea—Progesterone—uterine cancer	0.00112	0.00204	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—uterine cancer	0.0011	0.00201	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dactinomycin—uterine cancer	0.0011	0.002	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00109	0.00199	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—uterine cancer	0.00109	0.00198	CcSEcCtD
Nitroglycerin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00198	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—uterine cancer	0.00108	0.00197	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00108	0.00197	CcSEcCtD
Nitroglycerin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00196	CcSEcCtD
Nitroglycerin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00196	CcSEcCtD
Nitroglycerin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00195	CcSEcCtD
Nitroglycerin—Vertigo—Etoposide—uterine cancer	0.00106	0.00193	CcSEcCtD
Nitroglycerin—Abdominal pain—Dactinomycin—uterine cancer	0.00105	0.00192	CcSEcCtD
Nitroglycerin—Body temperature increased—Dactinomycin—uterine cancer	0.00105	0.00192	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00105	0.00192	CcSEcCtD
Nitroglycerin—Loss of consciousness—Etoposide—uterine cancer	0.00104	0.00189	CcSEcCtD
Nitroglycerin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00185	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—uterine cancer	0.001	0.00183	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000998	0.00182	CcSEcCtD
Nitroglycerin—Hypersensitivity—Dactinomycin—uterine cancer	0.00098	0.00179	CcSEcCtD
Nitroglycerin—Confusional state—Etoposide—uterine cancer	0.000971	0.00177	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Etoposide—uterine cancer	0.000963	0.00176	CcSEcCtD
Nitroglycerin—Infection—Etoposide—uterine cancer	0.000957	0.00175	CcSEcCtD
Nitroglycerin—Asthenia—Dactinomycin—uterine cancer	0.000955	0.00174	CcSEcCtD
Nitroglycerin—Tachycardia—Etoposide—uterine cancer	0.00094	0.00172	CcSEcCtD
Nitroglycerin—Skin disorder—Etoposide—uterine cancer	0.000935	0.00171	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Etoposide—uterine cancer	0.000931	0.0017	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000928	0.00169	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—uterine cancer	0.000925	0.00169	CcSEcCtD
Nitroglycerin—Hypotension—Etoposide—uterine cancer	0.0009	0.00164	CcSEcCtD
Nitroglycerin—Paraesthesia—Etoposide—uterine cancer	0.000865	0.00158	CcSEcCtD
Nitroglycerin—Dyspnoea—Etoposide—uterine cancer	0.000859	0.00157	CcSEcCtD
Nitroglycerin—Somnolence—Etoposide—uterine cancer	0.000856	0.00156	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—uterine cancer	0.000856	0.00156	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—uterine cancer	0.000846	0.00154	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—uterine cancer	0.000846	0.00154	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—uterine cancer	0.000846	0.00154	CcSEcCtD
Nitroglycerin—Vomiting—Dactinomycin—uterine cancer	0.000846	0.00154	CcSEcCtD
Nitroglycerin—Rash—Dactinomycin—uterine cancer	0.000839	0.00153	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000831	0.00152	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—uterine cancer	0.000825	0.00151	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—uterine cancer	0.000811	0.00148	CcSEcCtD
Nitroglycerin—Feeling abnormal—Etoposide—uterine cancer	0.000794	0.00145	CcSEcCtD
Nitroglycerin—Nausea—Dactinomycin—uterine cancer	0.00079	0.00144	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Etoposide—uterine cancer	0.000787	0.00144	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—uterine cancer	0.000783	0.00143	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—uterine cancer	0.000783	0.00143	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—uterine cancer	0.000783	0.00143	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—uterine cancer	0.000774	0.00141	CcSEcCtD
Nitroglycerin—Urticaria—Etoposide—uterine cancer	0.000765	0.0014	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—uterine cancer	0.000763	0.00139	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—uterine cancer	0.000762	0.00139	CcSEcCtD
Nitroglycerin—Abdominal pain—Etoposide—uterine cancer	0.000761	0.00139	CcSEcCtD
Nitroglycerin—Body temperature increased—Etoposide—uterine cancer	0.000761	0.00139	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—uterine cancer	0.000754	0.00138	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—uterine cancer	0.000751	0.00137	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—uterine cancer	0.000749	0.00137	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—uterine cancer	0.000732	0.00134	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—uterine cancer	0.000716	0.00131	CcSEcCtD
Nitroglycerin—Hypersensitivity—Etoposide—uterine cancer	0.00071	0.00129	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—uterine cancer	0.000705	0.00129	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—uterine cancer	0.000705	0.00129	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—uterine cancer	0.000705	0.00129	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—uterine cancer	0.000698	0.00127	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—uterine cancer	0.000693	0.00126	CcSEcCtD
Nitroglycerin—Asthenia—Etoposide—uterine cancer	0.000691	0.00126	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—uterine cancer	0.000689	0.00126	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—uterine cancer	0.000686	0.00125	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—uterine cancer	0.000685	0.00125	CcSEcCtD
Nitroglycerin—Pruritus—Etoposide—uterine cancer	0.000681	0.00124	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—uterine cancer	0.000679	0.00124	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—uterine cancer	0.000678	0.00124	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—uterine cancer	0.000666	0.00121	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—uterine cancer	0.000661	0.00121	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—uterine cancer	0.000652	0.00119	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—uterine cancer	0.000652	0.00119	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—uterine cancer	0.000638	0.00116	CcSEcCtD
Nitroglycerin—Dizziness—Etoposide—uterine cancer	0.000637	0.00116	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—uterine cancer	0.000635	0.00116	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000634	0.00116	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—uterine cancer	0.000628	0.00115	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—uterine cancer	0.000623	0.00114	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—uterine cancer	0.000616	0.00112	CcSEcCtD
Nitroglycerin—Vomiting—Etoposide—uterine cancer	0.000612	0.00112	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—uterine cancer	0.000612	0.00112	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—uterine cancer	0.000608	0.00111	CcSEcCtD
Nitroglycerin—Rash—Etoposide—uterine cancer	0.000607	0.00111	CcSEcCtD
Nitroglycerin—Dermatitis—Etoposide—uterine cancer	0.000607	0.00111	CcSEcCtD
Nitroglycerin—Headache—Etoposide—uterine cancer	0.000603	0.0011	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—uterine cancer	0.000594	0.00108	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—uterine cancer	0.000593	0.00108	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—uterine cancer	0.000585	0.00107	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—uterine cancer	0.000581	0.00106	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—uterine cancer	0.000577	0.00105	CcSEcCtD
Nitroglycerin—Nausea—Etoposide—uterine cancer	0.000572	0.00104	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—uterine cancer	0.000562	0.00103	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000559	0.00102	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—uterine cancer	0.00055	0.001	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—uterine cancer	0.000549	0.001	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—uterine cancer	0.000544	0.000993	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—uterine cancer	0.000541	0.000987	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—uterine cancer	0.00054	0.000985	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—uterine cancer	0.000538	0.000982	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—uterine cancer	0.000536	0.000979	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—uterine cancer	0.000531	0.000969	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—uterine cancer	0.000529	0.000966	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—uterine cancer	0.000527	0.000962	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—uterine cancer	0.000524	0.000957	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—uterine cancer	0.000522	0.000952	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000517	0.000944	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—uterine cancer	0.000504	0.000921	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—uterine cancer	0.000504	0.000919	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000499	0.000912	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—uterine cancer	0.000496	0.000906	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—uterine cancer	0.000491	0.000897	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—uterine cancer	0.00049	0.000894	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—uterine cancer	0.000487	0.00089	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—uterine cancer	0.000485	0.000886	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—uterine cancer	0.000485	0.000885	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000483	0.000881	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—uterine cancer	0.000481	0.000878	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—uterine cancer	0.00048	0.000876	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—uterine cancer	0.000467	0.000852	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000466	0.000851	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—uterine cancer	0.000449	0.000819	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—uterine cancer	0.000445	0.000813	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—uterine cancer	0.000445	0.000812	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—uterine cancer	0.000444	0.00081	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000441	0.000806	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000431	0.000787	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—uterine cancer	0.000429	0.000783	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—uterine cancer	0.000427	0.000779	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—uterine cancer	0.000427	0.000779	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—uterine cancer	0.000412	0.000751	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000408	0.000745	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—uterine cancer	0.000398	0.000726	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—uterine cancer	0.000397	0.000724	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—uterine cancer	0.000395	0.000721	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—uterine cancer	0.000395	0.000721	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—uterine cancer	0.000387	0.000707	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—uterine cancer	0.000382	0.000697	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—uterine cancer	0.000368	0.000672	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—uterine cancer	0.000358	0.000654	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—uterine cancer	0.000357	0.000652	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—uterine cancer	0.000353	0.000645	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—uterine cancer	0.000343	0.000626	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—uterine cancer	0.00034	0.000621	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—uterine cancer	0.00034	0.000621	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—uterine cancer	0.000338	0.000617	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—uterine cancer	0.00033	0.000603	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—uterine cancer	0.000321	0.000585	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—uterine cancer	0.000318	0.00058	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—uterine cancer	0.000315	0.000575	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—uterine cancer	0.000315	0.000574	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—uterine cancer	0.000313	0.000571	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—uterine cancer	0.000297	0.000542	CcSEcCtD
